HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects.

Abstract
Preservation of the chemical architecture of a cell or of an organism under changing and perhaps stressful conditions is termed homeostasis. An integral feature of homeostasis is the rapid expression of genes whose products are specifically dedicated to protect cellular functions against stress. One of the best known mechanisms protecting cells from various stresses is the heat-shock response which results in the induction of the synthesis of heat-shock proteins (HSPs or stress proteins). A large body of information supports that stress proteins--many of them molecular chaperones--are crucial for the maintenance of cell integrity during normal growth as well as during pathophysiological conditions, and thus can be considered "homeostatic proteins." Recently emphasis is being placed on the potential use of these proteins in preventing and/or treating diseases. Therefore, it would be of great therapeutic benefit to discover compounds that are clinically safe yet able to induce the accumulation of HSPs in patients with chronic disorders such as diabetes mellitus, heart disease or kidney failure. Here we show that a novel cytoprotective hydroxylamine derivative, [2-hydroxy-3-(1-piperidinyl) propoxy]-3-pyridinecarboximidoil-chloride maleate, Bimoclomol, facilitates the formation of chaperone molecules in eukaryotic cells by inducing or amplifying expression of heat-shock genes. The cytoprotective effects observed under several experimental conditions, including a murine model of ischemia and wound healing in the diabetic rat, are likely mediated by the coordinate expression of all major HSPs. This nontoxic drug, which is under Phase II clinical trials, has enormous potential therapeutic applications.
AuthorsL Vígh, P N Literáti, I Horváth, Z Török, G Balogh, A Glatz, E Kovács, I Boros, P Ferdinándy, B Farkas, L Jaszlits, A Jednákovits, L Korányi, B Maresca
JournalNature medicine (Nat Med) Vol. 3 Issue 10 Pg. 1150-4 (Oct 1997) ISSN: 1078-8956 [Print] United States
PMID9334730 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HSP70 Heat-Shock Proteins
  • Heat-Shock Proteins
  • Imides
  • Pyridines
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • bimoclomol
  • Luciferases
Topics
  • Animals
  • Cell Line
  • Cell Survival (drug effects)
  • Diabetes Mellitus, Experimental (physiopathology)
  • Embryo, Mammalian
  • HSP70 Heat-Shock Proteins (biosynthesis, genetics)
  • HeLa Cells
  • Heart (drug effects, physiology, physiopathology)
  • Heat Stress Disorders
  • Heat-Shock Proteins (biosynthesis)
  • Humans
  • Imides (pharmacology)
  • In Vitro Techniques
  • Luciferases (biosynthesis)
  • Male
  • Myocardial Ischemia (metabolism)
  • Myocardium (metabolism)
  • Promoter Regions, Genetic
  • Pyridines (pharmacology)
  • RNA, Messenger (biosynthesis)
  • Rats
  • Rats, Wistar
  • Recombinant Fusion Proteins
  • Skin (drug effects, pathology)
  • Transcription, Genetic (drug effects)
  • Transfection
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: